Free Trial Information
BioCentury | Nov 30, 2020
Finance

Kinaset jumps into severe asthma with $40M to develop inhaled JAK inhibitor

...an inhaled pan-JAK inhibitor from respiratory company Vectura Group...
...– Janus kinaseTSLP – Thymic stromal lymphopoietin Stephen Hansen Vectura Group...
Read More
BioCentury | Mar 12, 2020
Management Tracks

Hoerr takes helm from Menichella at CureVac; plus Genmab hires Mancini as COO, Tricida, Akcea, Refuge, Adaptate, Thermo Fisher and more

...He co-founded and served as CBO of Enterome Bioscience S.A. Inhaled drug delivery platform company Vectura Group...
...Therapeutics Inc. Refuge Biotechnologies Inc. GammaDelta Therapeutics Ltd. Thermo Fisher Scientific Inc. Fujifilm Holdings Corp. NGM Biopharmaceuticals Inc. Pharming Group N.V. Horama S.A. Vectura Group...
Read More
BioCentury | Nov 22, 2019

Dopamine receptor agonism for pulmonary fibrosis, liver fibrosis

...and collagen deposition in the respective organs. The DRD1 agonist Requip ropinirole is marketed by Vectura Group...
Read More
BioCentury | Oct 30, 2019
Company News

Management tracks: Vectura, Editas, Assembly, Camp4, Tempus, Passage Bio, Boundless Bio and Prometheus

...Inhaled drug delivery platform company Vectura Group plc (LSE:VEC) hired Will Downie as CEO and executive director...
...at the Aries Pharmaceuticals Inc. subsidiary of Cosmo Pharmaceuticals N.V. (SIX:COPN). Jonathan Block, Associate Editor Tempus Labs Inc. Vectura Group...
Read More
BioCentury | Aug 31, 2019
Product Development

Digital dollars: financing for digital health

...Series D $20.0 Boehringer Ingelheim GmbH , GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), Orion Corp. (HSE:ORNAV; HSE:ORBV), Vectura Group...
Read More
BioCentury | Jun 11, 2019
Company News

Management Tracks: Agios’ Biller to retire as CSO; plus Vectura, Molecular Partners, F-star and more

...Biller will retire at year end. The cellular metabolism company is searching for a successor. Vectura Group...
...co-founded. BioCentury Staff Agios Pharmaceuticals Inc. Biophytis S.A. Celsius Therapeutics eGenesis Inc. EyePoint Pharmaceuticals Inc. F-star Biotechnology Ltd. Medicure Inc. MediWound Ltd. Molecular Partners AG ReViral Ltd. Vectura Group...
Read More
BioCentury | Jan 8, 2019
Distillery Therapeutics

Cancer

...melanoma. Abbott Laboratories and AbbVie Inc. market the PPARα agonist TriLipix fenofibric acid for dyslipidemia. Vectura Group...
Read More
BioCentury | Nov 30, 2018
Clinical News

Vectura discontinues asthma therapy after Phase III miss

...an inhaled formulation of the corticosteroid budesonide delivered with Vectura’s Akita Jet smart inhalation system. Vectura Group...
...1 second (FEV1), Asthma Daily Diary (ACQ-5) and rescue medication Status: Development discontinued Milestone: NA Chris Lieu VR475 Vectura Group...
Read More
BioCentury | Oct 6, 2018
Finance

Seeking validation

...Inc. (NASDAQ:VNDA) / Bristol-Myers Squibb Co. (NYSE:BMY) Hetlioz tasimelteon Jet lag disorder Submit sNDA 4Q18 Vectura Group...
Read More
BioCentury | Sep 4, 2018
Financial News

Another C-suite departure at Immunocore

...Philadelphia, Pa.). CFO Paul Fry will step down from Immunocore's executive team by Oct. 26; Vectura Group...
Read More
Items per page:
1 - 10 of 266
BioCentury | Nov 30, 2020
Finance

Kinaset jumps into severe asthma with $40M to develop inhaled JAK inhibitor

...an inhaled pan-JAK inhibitor from respiratory company Vectura Group...
...– Janus kinaseTSLP – Thymic stromal lymphopoietin Stephen Hansen Vectura Group...
Read More
BioCentury | Mar 12, 2020
Management Tracks

Hoerr takes helm from Menichella at CureVac; plus Genmab hires Mancini as COO, Tricida, Akcea, Refuge, Adaptate, Thermo Fisher and more

...He co-founded and served as CBO of Enterome Bioscience S.A. Inhaled drug delivery platform company Vectura Group...
...Therapeutics Inc. Refuge Biotechnologies Inc. GammaDelta Therapeutics Ltd. Thermo Fisher Scientific Inc. Fujifilm Holdings Corp. NGM Biopharmaceuticals Inc. Pharming Group N.V. Horama S.A. Vectura Group...
Read More
BioCentury | Nov 22, 2019

Dopamine receptor agonism for pulmonary fibrosis, liver fibrosis

...and collagen deposition in the respective organs. The DRD1 agonist Requip ropinirole is marketed by Vectura Group...
Read More
BioCentury | Oct 30, 2019
Company News

Management tracks: Vectura, Editas, Assembly, Camp4, Tempus, Passage Bio, Boundless Bio and Prometheus

...Inhaled drug delivery platform company Vectura Group plc (LSE:VEC) hired Will Downie as CEO and executive director...
...at the Aries Pharmaceuticals Inc. subsidiary of Cosmo Pharmaceuticals N.V. (SIX:COPN). Jonathan Block, Associate Editor Tempus Labs Inc. Vectura Group...
Read More
BioCentury | Aug 31, 2019
Product Development

Digital dollars: financing for digital health

...Series D $20.0 Boehringer Ingelheim GmbH , GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), Orion Corp. (HSE:ORNAV; HSE:ORBV), Vectura Group...
Read More
BioCentury | Jun 11, 2019
Company News

Management Tracks: Agios’ Biller to retire as CSO; plus Vectura, Molecular Partners, F-star and more

...Biller will retire at year end. The cellular metabolism company is searching for a successor. Vectura Group...
...co-founded. BioCentury Staff Agios Pharmaceuticals Inc. Biophytis S.A. Celsius Therapeutics eGenesis Inc. EyePoint Pharmaceuticals Inc. F-star Biotechnology Ltd. Medicure Inc. MediWound Ltd. Molecular Partners AG ReViral Ltd. Vectura Group...
Read More
BioCentury | Jan 8, 2019
Distillery Therapeutics

Cancer

...melanoma. Abbott Laboratories and AbbVie Inc. market the PPARα agonist TriLipix fenofibric acid for dyslipidemia. Vectura Group...
Read More
BioCentury | Nov 30, 2018
Clinical News

Vectura discontinues asthma therapy after Phase III miss

...an inhaled formulation of the corticosteroid budesonide delivered with Vectura’s Akita Jet smart inhalation system. Vectura Group...
...1 second (FEV1), Asthma Daily Diary (ACQ-5) and rescue medication Status: Development discontinued Milestone: NA Chris Lieu VR475 Vectura Group...
Read More
BioCentury | Oct 6, 2018
Finance

Seeking validation

...Inc. (NASDAQ:VNDA) / Bristol-Myers Squibb Co. (NYSE:BMY) Hetlioz tasimelteon Jet lag disorder Submit sNDA 4Q18 Vectura Group...
Read More
BioCentury | Sep 4, 2018
Financial News

Another C-suite departure at Immunocore

...Philadelphia, Pa.). CFO Paul Fry will step down from Immunocore's executive team by Oct. 26; Vectura Group...
Read More
Items per page:
1 - 10 of 266